TABLE 4.
Temp (°C) | Crossa | Cleistothecium production |
Cleistothecium density (no. of cleistothecia/cm2) |
Ascospore viability (%) |
---|---|---|---|---|
30 | A4 × A4 | Yes | 15.0 ± 0.81 | 91.83 ± 3.53 |
MO × MO | Yes | 7.0 ± 1.35 | 92.83 ± 3.96 | |
SP × SP | Yes | 0.25 ± 0.25 | 89.83 ± 3.51 | |
MO × R21 | Yes | 1.25 ± 0.25 | 94.83 ± 3.85 | |
SP × R21 | No | |||
37 | A4 × A4 | Yes | 9.75 ± 1.43 | 90.67 ± 3.62 |
MO × MO | Yes | 5.25 ± 1.31 | 92.5 ± 2.76 | |
SP × SP | No | |||
MO × R21 | Yes | 5.0 ± 0.40 | 92.5 ± 1.28 | |
SP × R21 | No |
A4, FGSC A4 reference strain; MO, MO80069 clinical isolate; SP, SP-2605-48 clinical isolate; R21, R21XR135, paba-deficient strain.